University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
NCT Number: NCT03834168
The purpose of the study to assess the diurnal rhythm in natriuretic peptide levels and its temporal relationship with nocturnal blood pressure in obese and African-American individuals as compared with lean and white individuals.
Looking for future studies?
Notify Me18 year–40 year
Male
Interventional
Not applicable
Birmingham, Alabama, 35294, United States
Obese and African-American individuals are at greater risk for cardiovascular morbidity and mortality than lean and white individuals. One of the key reasons for this health disparity is a higher risk of hypertension among obese and African-American individuals. The reasons for why these disparities develop are not well understood.
Natriuretic peptides are hormones produced by the heart and have a wide range of favorable cardiovascular effects such as natriuresis (sodium excretion), vasodilation, and direct inhibition of the renin-angiotensin-aldosterone system. Human studies showed the existence of 24-hour (diurnal) variations in the circulating natriuretic peptide levels.
Prior work from the investigators and others demonstrated that individuals with genetically-determined lower circulating natriuretic peptides levels have higher blood pressure and greater risk of hypertension. Further, the investigators have shown that obesity and African-American race are associated with lower natriuretic peptide levels, suggesting that relatively low natriuretic peptide levels may be a biologic determinant contributing to health disparities.
Obese and African-American individuals have a greater prevalence of nocturnal hypertension [nighttime blood pressure >120/80 mmHg], which is an independent risk factor for cardiovascular events. The underlying reasons for 24-hour variations in blood pressure are unknown.
The investigators hypothesize that loss of the natural 24-hour rhythm of natriuretic peptide levels plays a role in the development of nocturnal hypertension in obese and African-American individuals. The aims of this study are:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Standardized diet consisted with eucaloric meals with 4.5 gm of sodium per day for 5 days.
Time frame: About 24 hours on the in-patient study visit day after consuming study meals for 5 days
Assess the diurnal rhythm in circulating MRproANP levels among obese individuals and compared it with lean individuals
Time frame: About 24 hours on the in-patient study visit day after consuming study meals for 5 days
Assess relationship between 24-hour variability of MRproANP levels and 24-hour patterns of blood pressure and whether this relationship of rhythmicity of MRproANP levels and nocturnal blood pressure differed in obese and lean individuals and by race
Time frame: About 24 hours on the in-patient study visit day after consuming study meals for 5 days
Assess the diurnal rhythm in circulating MRproANP levels among African-American individuals and compared it with white individuals
University of Alabama at Birmingham
Other
The Diurnal Rhythm in Natriuretic Peptide Levels and Relationship With Nocturnal Blood Pressure
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04971720
Body Weight, Cardiovascular Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT05216042
Behavior, Body Weight
Birmingham, Alabama, United States
View Trial DetailsNCT05067231
Body Weight, Cardiovascular Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT03072602
Glucose Metabolism Disorders, Healthy
Birmingham, Alabama, United States
View Trial Details